Robert C. Daigle
Robert C. Daigle's purchase track record
How the stock did after each of Robert C. Daigle's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/14/2025 | ASYS | $27K | +41.9% | +118.1% | +16.3% |
| 2/13/2024 | ASYS | $15K | +25.9% | +29.3% | +9.7% |
| 12/18/2023 | ASYS | $260K | +20.0% | +50.4% | +15.5% |
| 8/24/2023 | ASYS | $105K | -11.6% | -44.1% | +16.2% |
| 8/11/2023 | ASYS | $168K | -19.7% | -61.3% | +12.6% |
| 5/12/2023 | ASYS | $27K | +1.6% | -18.4% | +7.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Roche presents new Phase III data and FDA approval. Roche reported new one-year Phase III data for vamikibart in treating uveitic macular edema, a condition causing vision loss. Additionally, the FDA approved Tecentriq for adjuvant treatment of stage III colon cancer. These developments reflect ongoing progress in the company's clinical pipeline and regulatory approvals.
Transaction History
| ASYS | ▲ Buy | Open Market | 355 | $1K | 5/16/2025 | View on chart |
| ASYS | ▲ Buy | Open Market | 2,498 | $9K | 5/15/2025 | View on chart |
| ASYS | ▲ Buy | Open Market | 5,000 | $17K | 5/14/2025 | View on chart |
| ASYS | ▲ Buy | Option Exercise | 55,556 | $0 | 8/14/2024 | View on chart |
| ASYS | ▼ Sell | Tax Withholding | 15,472 | $98K | 8/14/2024 | View on chart |
| ASYS | ▲ Buy | Option Exercise | 7,854 | $0 | 3/1/2024 | View on chart |
| ASYS | ▼ Sell | Tax Withholding | 2,603 | $13K | 3/1/2024 | View on chart |
| ASYS | ▲ Buy | Open Market | 3,500 | $15K | 2/13/2024 | View on chart |
| ASYS | ▲ Buy | Open Market | 20,000 | $78K | 12/19/2023 | View on chart |
| ASYS | ▲ Buy | Open Market | 46,000 | $182K | 12/18/2023 | View on chart |
| ASYS | ▲ Buy | Open Market | 4,000 | $34K | 8/25/2023 | View on chart |
| ASYS | ▲ Buy | Open Market | 8,250 | $71K | 8/24/2023 | View on chart |
| ASYS | ▲ Buy | Open Market | 1,000 | $9K | 8/16/2023 | View on chart |
| ASYS | ▲ Buy | Open Market | 1,200 | $11K | 8/16/2023 | View on chart |
| ASYS | ▲ Buy | Open Market | 233 | $2K | 8/15/2023 | View on chart |
| ASYS | ▲ Buy | Open Market | 49 | $441 | 8/14/2023 | View on chart |
| ASYS | ▲ Buy | Open Market | 1,000 | $9K | 8/14/2023 | View on chart |
| ASYS | ▲ Buy | Open Market | 15,386 | $137K | 8/11/2023 | View on chart |
| ASYS | ▲ Buy | Open Market | 84 | $735 | 5/19/2023 | View on chart |
| ASYS | ▲ Buy | Open Market | 3,000 | $26K | 5/12/2023 | View on chart |
| ROG | ▼ Sell | Tax Withholding | 208 | $31K | 2/14/2023 | View on chart |
| ROG | ▼ Sell | Tax Withholding | 226 | $34K | 2/12/2023 | View on chart |
| ROG | ▼ Sell | Tax Withholding | 165 | $25K | 2/10/2023 | View on chart |
| ROG | ▲ Buy | Grant | 616 | $0 | 2/9/2023 | View on chart |
| ROG | ▼ Sell | Tax Withholding | 205 | $31K | 2/9/2023 | View on chart |
| ROG | ▲ Buy | Grant | 2,230 | $0 | 2/14/2022 | View on chart |
| ROG | ▼ Sell | Tax Withholding | 352 | $96K | 2/12/2022 | View on chart |
| ROG | ▼ Sell | Tax Withholding | 263 | $72K | 2/10/2022 | View on chart |
| ROG | ▲ Buy | Grant | 4,218 | $0 | 2/9/2022 | View on chart |
| ROG | ▼ Sell | Tax Withholding | 1,876 | $512K | 2/9/2022 | View on chart |
| ROG | ▼ Sell | Tax Withholding | 367 | $100K | 2/7/2022 | View on chart |
| ROG | ▼ Sell | Open Market | 3,083 | $836K | 11/2/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
ASYS mentioned in discussion of lagging computer and tech stocks
A recent Yahoo article highlighted that computer and technology stocks have been underperforming this year. Amtech Systems, as a technology company, is included in that broader sector trend. The commentary may influence investor sentiment as the stock continues to trade near its recent support level.
ASYS mentioned in discussion of lagging computer and tech stocks. A recent Yahoo article highlighted that computer and technology stocks have been underperforming this year. Amtech Systems, as a technology company, is included in that broader sector trend. The commentary may influence investor sentiment as the stock continues to trade near its recent support level.